The 2025 BIO International Convention highlighted the critical need for sustained collaboration between government agencies and the biotech industry to enhance America's biodefense capabilities. Government officials emphasized the urgency of partnering with biotechs capable of producing medical countermeasures (MCMs) that can be reliably manufactured and sustained, especially within the U.S., to secure the Strategic National Stockpile. Panelists underscored the importance of BIO’s role as a mediator in facilitating these collaborations to address emerging health security threats effectively.